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Introduction
Recurrent early miscarriages, defined as three or more consecutive miscarriages, affect up to 5% of fertile couples (Bulletti et al., 1996; Coulam et al., 1997; Jauniaux et al., 2006; Stirrat, 1990) . Several factors have been directly associated with recurrent miscarriage including parental karyotype anomalies, maternal autoimmune diseases, such as antiphospholipid syndrome, hereditary maternal thrombophilia and endocrine disorders (Bohlmann et al., 2009; Jauniaux et al., 2006; Rey et al., 2003) . However, there is an ongoing debate about possible causes of recurrent miscarriages and sole associations, as the exact pathophysiology of the majority of risk factors has not been precisely described (Jauniaux et al., 2006) . Furthermore, not all females with identified risk factors, e.g. thrombophilic disorders, although having a higher risk for miscarriage in a first intended pregnancy (Lissalde-Lavigne et al., 2005) will necessarily suffer from pregnancy complications (Murphy et al., 2000) .
Uterine anomalies are usually divided into congenital and acquired forms. Congenital, or Müllerian, anomalies include fusion anomalies or partial agenesis of the developing uterus such as septate, bicornuate, didelphic or unicornuate variants. They have been attributed to recurrent pregnancy complications such as late or recurrent early miscarriages, abnormal fetal presentation, intrauterine growth restriction, prematurity and a higher rate of Caesarean sections (Grimbizis et al., 1998; Homer et al., 2000; Zlopasa et al., 2007) . In the general population, Müllerian defects, including uterine septum as the most common form, are found with a prevalence of 2-5%, whereas this rate may rise up to 20% in patients with more than two miscarriages (Ashton et al., 1988; Hornemann et al., 2009; Salim et al., 2003; Saravelos et al., 2008) . A septate uterus is the most common congenital anomaly and associated with a rate of spontaneous miscarriage >60% (Homer et al., 2000) . It has been shown that the presence of such surgically untreated midline uterine defects is correlated with a higher rate of miscarriage of euploid embryos in consecutive pregnancies in patients with a history of recurrent miscarriages (Sugiura-Ogasawara et al., 2009 ). Furthermore, a number of acquired uterine anomalies such as fibroids, intrauterine adhesions and endometrial polyps have been described with varying prevalence in patients with recurrent miscarriages, although their direct influence on miscarriages is not completely understood (Bettocchi et al., 2008; Hornemann et al., 2009) . Contrary, intrauterine adhesions, most often seen after sharp curettage (Robinson et al., 2008) , have been clearly associated with recurrent miscarriage (Schenker, 1996) .
Traditionally, international guidelines recommend a thorough investigation after at least three early consecutive miscarriages (German Society for Gynaecology and Obstetrics, 2008; Jauniaux et al., 2006) . However, some authors also suggest starting an extensive examination in women with exactly two consecutive miscarriages (German Society for Gynaecology and Obstetrics, 2008; Li et al., 2002) , especially if the women are older than 30 years. Including patients after two miscarriages increases the number of patients examined and thus the cost for the healthcare system, although these patients might still have a good chance of a normal pregnancy and birth in a subsequent pregnancy (Brigham et al., 1999) . Therefore, identifying specific risk factors after two miscarriages might be of importance in order to avoid unnecessary diagnostic procedures as well the burden of 'waiting' for a third miscarriage and starting an evaluation not before then.
The aim of this study was to analyse the hysteroscopic frequency of congenital and acquired uterine anomalies in patients with exactly two early miscarriages and to compare them with women with three or more early miscarriages.
Materials and methods
This study retrospectively analysed the files of patients referred for recurrent early miscarriages (less than completed 14 weeks of gestation) at the respective departments of the University Hospitals of Heidelberg and Luebeck in Germany. They formed a consecutive cohort of patients, with the hysteroscopy of the last patient included performed in February 2009, who are identically screened for established risk factors for recurrent miscarriages according to a special protocol as described elsewhere (Bohlmann et al., 2007) . In brief, parental karyotype anomalies, maternal autoimmune diseases, such as antiphospholipid syndrome, hereditary maternal thrombophilia (factor V Leiden mutation, prothrombin mutation, protein S deficiency) and endocrine disorders such as hypothyroidism and hyperprolactinaemia were examined. As the presence of these factors does not necessarily rule out uterine anomalies in women with recurrent miscarriages, there were no exclusion criteria.
According to the criteria of Weiss et al. (2005) miscarriage was defined as: (i) a spontaneous expulsion of products of conception; the disappearance of fetal heart activity on ultrasound; (ii) a gestational sac which did not grow in consecutive ultrasound examinations; or (iii) the b-human chorionic gonadotrophin failing to rise in serial measurements. Women were included in the analysis if three or more consecutive miscarriages had occurred before or if they had had exactly two consecutive miscarriages. Contrary to the publication of Weiss et al. (2005) , miscarriages were only counted if they had occurred before 14 completed weeks of gestation. This restriction was applied to exclude a possible bias due to late miscarriages of infectious causes (Hay et al., 1994) . Histologically diagnosed molar pregnancies were excluded from analysis as well as terminations of pregnancy for social reasons.
Furthermore, data were collected on the patients' ages, numbers of previous pregnancies and week of previous miscarriages.
After informed consent was obtained an office hysteroscopy was performed according to the national guidelines for the examination of patients with recurrent miscarriages. Generally, a thorough examination of the patient, including two-dimensional transvaginal ultrasound, had been previously performed. Hysteroscopy was performed in the proliferative phase in a comparable manner in both departments, usually between day 5 and 10 of the menstrual cycle. Cervical dilatation to enable the insertion of the hysteroscope was performed when necessary with a solution of isotonic sodium chloride being used as distention medium. Local anaesthetic or general anaesthesia, especially when desired by the patient, was used. A conversion to operative hysteroscopy in general anaesthesia was possible in all cases in both departments and usually applied when anomalies were found.
Findings were classified as normal or abnormal with the latter being subdivided into acquired or congenital anomalies. Examples for acquired anomalies were submucosal fibroids with endometrial displacement, intrauterine adhesions and endometrial polyps, whereas the presence of congenital anomalies was diagnosed when an arcuate uterus or various Müllerian anomalies were found. The latter were usually confirmed by laparoscopy to differentiate between complete septate and didelphic uterus or between partially septate and bicornuate uterus.
According to calculations (N-Query advisor; Statcon, Witzenhausen, Germany), 43 patients in each arm of the study were needed in order to achieve a power of 80% with an alpha = 0.05 in order to detect an increase in anomalies from 10 to 35%. The numbers used in this calculation were chosen according to the hysteroscopically detected incidences of congenital (2-5%; Ashton et al., 1988; Salim et al., 2003) and acquired anomalies in asymptomatic patients and in patients with infertility (>30%; Hornemann et al., 2009 ). Data are presented as means or proportions ± standard deviation. Categorical variables were compared by the Mann-Whitney U-test and were considered statistically significant when two-tailed analysis yielded P < 0.05. Statistical analyses were performed with Prism 4.0 for Windows (GraphPad Software, 2003 ; San Diego, CA, USA). Fisher's exact test (Statistical Package for Social Sciences, version 16.0 for Windows; SPSS, Chicago, IL, USA) was used for comparing non-continuous variables between groups. A P-value < 0.05 was again considered significant.
Results
A total of 206 patients met the inclusion criteria, 87 of whom had suffered from two early miscarriages (group A) whereas group B consisted of 119 women with three or more early consecutive miscarriages. Study demographics and the prevalence of risk factors for recurrent miscarriage are presented in Table 1 .
Uterine anomalies were found in 36.8% (group A) and 42.9% (group B) of patients ( Table 2) . In group A, eight of the 87 (9.2%) women were found to have various congenital anomalies and this rate was not significantly higher in group B (16.8%). The rate of acquired uterine anomalies was almost identical (28.7 versus 27.7%). Except for prior deliveries (P = 0.005), no significantly different clinical parameters were observed between the two groups (Table 2). Table 3 displays the different anomalies found in both groups. The results were not statistically different either, when arcuate uteri were excluded (data not shown). Retrospective analysis of ultrasound sensitivity is described in Table 4 .
Cervical polyps were not detected in either group. No complications (cervical tears, via falsa, uterine perforation, infection) occurred during or after hysteroscopy.
Discussion
Uterine abnormalities are estimated to play a causal role in a substantial number of couples seeking treatment for infertility (Wallach, 1972) . Their assumed pathophysiological mechanism is that they impair proper embryo implantation and growth due to poor vascularization with subsequent infertility or miscarriage (Brown et al., 2000) . The rate of uterine anomalies is reported as 2-5% in women with a good obstetric history or those at low risk for complications (Ashton et al., 1988; Salim et al., 2003) , whereas more than 30% of infertile patients are reported to suffer from abnormal intrauterine findings (Hornemann et al., 2009) . A wide discrepancy (from 6.3 to 67%) of the rate of anomalies has been described for patients with recurrent pregnancy losses (Weiss et al., 2005) . These findings mirror differences in study designs and the variations of anomalies reported in the respective studies (Weiss et al., 2005) . According to this Values are mean ± SD (range) or number (%). a P = 0.005.
study's power analysis, 43 patients in each arm were sufficient to detect an increase in uterine anomalies from 10 to 35% between the two groups. Methodologically, hysteroscopic findings in an asymptomatic, fertile control group of patients with comparable demographic parameters examined in the same institution would help to elucidate the baseline incidence of uterine anomalies. Such a diagnostic, albeit surgical, approach in individuals without symptoms is unlikely to meet the approval of an ethics committee, impeding a comparison between control women and patients with exactly two miscarriages. The approach in this study was chosen to contribute to the ongoing debate about uterine anomalies in those patients. Congenital uterine anomalies only are reported to be found in about 17% of patients with recurrent miscarriages (Saravelos et al., 2008) . In the present analysis, the incidence of congenital anomalies in group B was about double that in group A. However, this finding did not reach statistical significance due to small overall numbers of congenital anomalies. However, it was the different incidence of congenital anomalies that mainly accounted for the non-significantly differing overall differences of uterine anomalies, as the incidence of acquired anomalies was almost identical in both groups. Larger numbers of patients may help to make substantial contributions to the question, whether the incidence of congenital uterine anomalies in patients with exactly two miscarriages is significantly different from those with more miscarriages.
Whereas the significance of other Müllerian anomalies for the development of pregnancy complications is established the role of arcuate uteri in the development of miscarriages is not that clear and may be discussed controversially (Acien, 1993; Raga et al., 1997; Weiss et al., 2005; Woelfer et al., 2001) . It was decided to include arcuate uteri in the current analysis as they are generally accepted and described as a congenital anomaly in an established classification system (American Fertility Society, 1988) and arcuate uteri were found with non-significantly different prevalences of 2.3% and 5.0% in groups A and B, respectively. However, even after exclusion of patients with arcuate Table 3 Specific anomalies found in both groups of patients with repeated early miscarriages. Values are number (%). Absolute numbers may differ due to the presence of combined anomalies. There were no statistically significant differences between the two groups.
uteri, the rates of uterine anomalies were not statistically different between both groups, either. Thus, the inclusion or exclusion of arcuate uteri, with simultaneous consideration of its controversially discussed role, does not contribute significantly to the quintessence of this study.
Other risk factors, such as antiphospholipid syndrome and paternal karyotype anomalies, are established to contribute to recurrent miscarriages. However, it was not the aim to detect uterine anomalies in women with otherwise idiopathic recurrent miscarriages but to analyse them in women with repeated miscarriages in general. This was due to the fact that a complete, thorough investigation, also excluding the presence of uterine anomalies, is generally recommended in women with recurrent miscarriages. Therefore, other established risk factors did not serve as exclusion criteria.
Traditionally, recurrent pregnancy loss is defined after three early miscarriages, although some authors assume a similar outcome in a subsequent pregnancy when patients with only two miscarriages are examined (Chauhan and Moghissi, 2002) . Although women with a 'low number' of miscarriages generally have a good prognosis in a subsequent pregnancy (Brigham et al., 1999) , specific factors such as congenital uterine anomalies (Hickok, 2000) or antiphospholipid syndrome are associated with a high percentage of pregnancy wastage. These concerns are met in some publications (Li et al., 2002) and support extensive examinations in patients with (only) two early miscarriages, especially if they are older than 30 years (German Society for Gynaecology and Obstetrics, 2008) .
Diagnostic methods to assess the inner architecture of the uterus include transvaginal ultrasound (two-or threedimensional), hysterosalpingography (HSG), sonohysterography (SHG) and hysteroscopy. Today, it is generally accepted that hysteroscopy, possibly in combination with laparoscopy, SHG and three-dimensional ultrasound are the most accurate procedures in the diagnosis of congenital uterine anomalies (Ghi et al., 2008; Saravelos et al., 2008) . Hysteroscopy is generally regarded to be essential when intrauterine pathology is suspected at transvaginal ultrasound, HSG or SHG (Bozdag et al., 2008) . However, even if no anomalies are found with the latter diagnostic tools, subtle intrauterine pathologies may be detected at hysteroscopy in 25-50% of patients (Bozdag et al., 2008; Demirol and Gurgan, 2004) . Consequently, two-dimensional ultrasound and HSG are considered to be inadequate for diagnostic purposes as they are less accurate (Saravelos et al., 2008) . A comparison of sonographic results (either two-or three-dimensional) with hysteroscopic findings was not the aim of the present study, as current guidelines consider hysteroscopy to be the diagnostic method of choice for patients with repeated miscarriages (German Society for Gynaecology and Obstetrics, 2008) .
Contrary to SHG and ultrasound, hysteroscopy offers both a diagnostic and direct therapeutic approach of intrauterine congenital anomalies and acquired anomalies such as adhesions, fibroids and polyps. A therapeutic intervention, e.g. hysteroscopic septum dissection or adhesiolysis, may improve the outcome in subsequent pregnancies (Colacurci et al., 1996; El-Toukhy et al., 2008; Grimbizis et al., 1998; Hickok, 2000; Ozgur et al., 2007; Zikopoulos et al., 2004) , although large prospective randomized trials on the subject are still missing. The role of other acquired uterine anomalies such as polyps remains in debate (Hornemann et al., 2009) .
Up to now, however, the rate of congenital or acquired uterine anomalies in patients with two early miscarriages is not sufficiently described: The study of Portuondo et al. (1986) , using an approach with conventional hysterosalpingography, described similar rates of uterine anomalies in patients with two and three miscarriages. However, conventional hysterosalpingography is nowadays not regarded as a standard procedure due to its association with exposure to radiation and its reduced accuracy compared with the gold-standard hysteroscopy (Bettocchi et al., 2004; Golan et al., 1996; Preutthipan and Linasmita, 2003) showing an overall correlation between both procedures of only 73% (Roma Dalfó et al., 2004) . Weiss et al. (2005) performed hysteroscopic examinations in 165 women with exactly two or with more miscarriages. However, their study included a substantial number of patients with second-trimester miscarriages. These miscarriages, however, may have a completely different aetiology, e.g. bacterial infections (Hay et al., 1994) with abnormal vaginal colonization, intra-amniotic infection and subsequent premature rupture of membranes. This association is less prevalent in first-trimester miscarriages (Michels and Tiu, 2007) or even in patients with recurrent early miscarriages (Bohlmann et al., 2007) , which may thus have led to a bias in the analysis. Therefore, the present study was restricted to women with recurrent first-trimester complications.
There are some limitations to this study in addition to its retrospective approach. It was not possible to confirm a significantly different prevalence of adhesions in patients with exactly two or with more early miscarriages, although it is generally accepted that the rate of intrauterine adhesions increases when a considerable number of sharp curettages have been previously performed (Friedler et al., 1993) . This result may be due to the fact that curettages had not been previously performed in all, especially very early, cases of miscarriages, leading to a possible bias. There was no control group of fertile women of the same age to identify the baseline prevalences of uterine anomalies in women without a history of miscarriages. However, this approach would have been completely different, as the aim was to compare patients with two and with more miscarriages to find the most appropriate time point, when hysteroscopy seems to be justified. Additionally, this study was not aimed to describe differences of the extent of acquired uterine anomalies, such as the severity of adhesions or the size of submucous fibroids (Vimercati et al., 2007) . It cannot be excluded that such characteristics may be of importance as risk factors for miscarriages in subsequent pregnancies. The therapeutic significance of surgery on uterine anomalies in patients with exactly two miscarriages was not to be addressed in this study, either and is subject to an ongoing analysis of subsequent pregnancy outcome.
Hysteroscopy is generally well tolerated, especially when performed in the variation of an office hysteroscopy. Furthermore, it was not the aim to compare different diagnostic methods with respect to detection rates of uterine anomalies (De Feuce et al., 2009; Guimarães Filho et al., 2006) . However, due to the high number of anomalies detected, the present study gives further support to consider hysteroscopy as an important procedure even in patients with only two miscarriages, although studies comparing hysteroscopy and other diagnostic methods in such patients are still needed.
Overall, according to theses results, women after exactly two early miscarriages can be advised that hysteroscopy will reveal uterine anomalies in more than 35% of patients, the majority of which are amenable to therapy. The significance of the high rates of uterine anomalies, particularly acquired ones, in patients with exactly two early miscarriages is not clear, especially when the good outcome of future pregnancies in these patients is taken into account.
A study concerning the outcome of subsequent pregnancies in those patients with two early miscarriages and operative correction of uterine anomalies is ongoing. However, as the likelihood of finding a uterine anomaly is not significantly different from patients with three and more early miscarriages, the hysteroscopic approach might be a diagnostic option in patients with exactly two consecutive early miscarriages as well. It may help to identify those women with a higher risk to miscarry in a subsequent pregnancy, even if other diagnostic tools were not able to show intrauterine anomalies.
